Evoke Pharma Inc (EVOK)

NASDAQ
3.2200
-0.0200(-0.62%)
After Hours
3.1300
-0.0900(-2.795%)
- Real-time Data
  • Volume:
    31,097
  • Day's Range:
    3.1206 - 3.3300
  • 52 wk Range:
    2.0300 - 18.9600

EVOK Overview

Prev. Close
3.24
Day's Range
3.1206-3.33
Revenue
1.95M
Open
3.24
52 wk Range
2.03-18.96
EPS
-2.99
Volume
31,097
Market Cap
10.76M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,273,951
P/E Ratio
-
Beta
0.6
1-Year Change
-79.52%
Shares Outstanding
3,343,071
Next Earnings Date
10 Aug 2022
What is your sentiment on Evoke Pharma?
or
Market is currently closed. Voting is open during market hours.

Evoke Pharma Inc News

Evoke Pharma Inc Company Profile

Evoke Pharma Inc Company Profile

Employees
4

Evoke Pharma, Inc. (Evoke) is a specialty pharmaceutical company that owns and operates in the development and commercialization of pharmaceutical products. The Company is focused primarily on the development and commercialization of drugs to treat gastrointestinal (GI) disorders and diseases. Evoke is developing its product Gimoti (metoclopramide) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis. Gimoti, is a dopamine antagonist / mixed 5-HT3 antagonist / 5-HT4 agonist with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti is a formulation of metoclopramide offering systemic delivery by nasal spray administration.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellNeutralNeutralStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong BuyStrong Sell
SummaryStrong SellStrong SellSellBuyStrong Sell